JP Morgan cuts Dyne Therapeutics rating to Underweight
JP Morgan cut Dyne Therapeutics’ rating to Underweight from Neutral, according to Benzinga.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
JP Morgan cut Dyne Therapeutics’ rating to Underweight from Neutral, according to Benzinga.